Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03124303 · ClinicalTrials.gov registry record

Interventions for Postoperative Delirium: Biomarker-3

A clinical trial of Delirium, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
468
Enrollment target
1
Study location

NCT03124303 is a study of Delirium that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 468 participants, below the 880-participant average among 62 other Delirium trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03124303, a study of Delirium, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
468 participants
Enrollment target
1
Study location

Study Summary

The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.

Conditions Studied

Interventions

  • PROCEDURE Magnetic Resonance Imaging
  • PROCEDURE High Density-Electroencephalogram
  • PROCEDURE Blood specimen collection
  • DIAGNOSTIC_TEST Pupillometry

Study Locations (1)

Wisconsin

  • University of Wisconsin-Madison - Madison

Trial Details

FieldValue
Enrollment Target 468 participants
Start Date 2017-02-13
Est. Completion 2029-12

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT03124303

The ClinicalTrials.gov registry entry for NCT03124303 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 468 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 62 other Delirium trials with a reported enrollment target (47% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 4 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT03124303 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03124303 about?

NCT03124303 is a clinical study titled "Interventions for Postoperative Delirium: Biomarker-3". The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.

What is the current status of trial NCT03124303?

This trial is currently recruiting. The enrollment target is 468 participants. The study started on 2017-02-13. Estimated completion is 2029-12.

What conditions does trial NCT03124303 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT03124303?

The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), High Density-Electroencephalogram (PROCEDURE), Blood specimen collection (PROCEDURE), Pupillometry (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03124303?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03124303 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.